Global Antimicrobial Susceptibility Testing Market | North America to occupy 40% market share, faster growth expected in APAC and Europe | Technavio

May 24, 2021

NEW YORK, May 24, 2021 /PRNewswire/ — The antimicrobial susceptibility testing market is projected to grow by USD 936.87 million, registering a CAGR of over 5% during 2021-2025. Technavio’s report on the antimicrobial susceptibility testing market covers the market outlook and growth prospects during the forecast period.

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Request a Free Sample Report

Technavio’s research study provides comprehensive information on the factors affecting the growth of the antimicrobial susceptibility testing market across the following regions.

North America
Europe
Asia
ROW

Antimicrobial Susceptibility Testing Market in North America:

“North America occupied about 40% of the market share in 2020 and the region is offering significant growth opportunities for market vendors. The growing emphasis on the discovery of new drugs is increasing the use of antimicrobial susceptibility testing by pharmaceutical and biotechnology companies in the region. In addition, the emergence of new diseases and the high prevalence of chronic diseases are creating strong demand in the North American market,” says a senior analyst at Technavio.

Every year, more than two million people are diagnosed with an antibiotic-resistant infection in the US alone. This is forcing the US government to take several initiatives to control such drug-resistant infections, which is increasing the need for the development and use of rapid diagnostics. Such developments are fueling the growth of the market in North America. The revenue contribution to the market in North America will be maximum from the US.

Antimicrobial Susceptibility Testing Market in Europe:

“The rising prevalence of infectious diseases and the increasing expenditure on healthcare will provide significant opportunities for market vendors operating in the European market,” says a senior analyst at Technavio.

The market is expected to register a 5.60% CAGR in Europe during 2021-2025. The increasing awareness about the control and spread of drug-resistant infections will be crucial in driving the antimicrobial susceptibility testing market growth in Europe. The revenue contribution to the market in Europe will be maximum from countries such as Germany and the UK.

Antimicrobial Susceptibility Testing Market in Asia:

“The market is observing an increase in the number of research activities in countries such as China, Japan, and Singapore. This is increasing the awareness as well as the adoption of antimicrobial susceptibility testing among healthcare specialists and academicians, which is positively influencing the market growth,” says a senior analyst at Technavio.

The market is expected to register a 6.00% CAGR in APAC during the forecast period. The increasing applications of AST in fields of toxicology, in-vitro and in-vivo modeling, infectious disease, antimicrobial drug stewardship, laboratory medicines, and others are fueling the growth of the antimicrobial susceptibility testing market in Asia. Japan and China are the major markets for antimicrobial susceptibility testing in the region.

Know about the major factors impacting the growth of the market across other regions by downloading our free sample report:

www.technavio.com/talk-to-us?report=IRTNTR41650

The global antimicrobial susceptibility testing market is driven by the following factors:

Increased use of antimicrobial susceptibility testing by biopharmaceutical companies
Increasing prevalence of infectious diseases
Increasing government initiatives

Based on the application, the report segments the antimicrobial susceptibility testing market by clinical diagnostics, drug discovery and development, and others.

The clinical diagnostics segment registered maximum growth in the market in 2020. The segment is driven by the growing use of AST by hospitals and diagnostic centers to ensure the quality of care and patient safety. Also, the rising awareness about personalized medicines is contributing to the growth of the segment.

Subscribe to our most popular “Lite Plan” at only $ 3000 per year and avail following benefits

View 3 reports monthly!
Download 3 reports annually!
Get lifetime access to our Technavio Insights!

Top vendors highlighted in the Antimicrobial susceptibility testing Market Report:

The report offers insights on key products offered and business strategies adopted by major vendors including,

Accelerate Diagnostics Inc.
ALIFAX Srl
Becton, Dickinson and Co.
bioMerieux SA
Bio-Rad Laboratories, Inc

Browse Related Reports:

Customers who bought this report also purchased,

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

Technavio’s Newsroom: newsroom.technavio.com/news/antimicrobial-susceptibility-testingmarket

Report: www.technavio.com/report/antimicrobial-susceptibility-testing-market-industry-analysis